Back

Beta-blockers in hypertensive patients with comorbidities: where do we stand?

2 September 2019 (10:15 - 10:27)
Organised by:
Congress Presentation Part of: Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: what is the rationale? Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Christoph Maack

University Clinic Wuerzburg, Wuerzburg (Germany)

2 More presentations in this session

Presentation thumbnail
Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: Why, when and for whom are they in line with the guidelines?
Doctor J. Wolf (Gdansk, PL)
Slides Video
Presentation thumbnail
Discussion
Professor C. Maack (Wuerzburg, DE) Professor K. Tsioufis (Athens, GR) Doctor J. Wolf (Gdansk, PL)
Slides Video

Access the full session

Session thumbnail
Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: what is the rationale?

The Event

Event poster

ESC Congress 2019

2 September 2019 10:15 CET
You may be interested in
thumbnail
Congress Presentation
What is new in hypertension: highlights from the 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension
thumbnail
Congress Presentation
Add-on treatment with zilebesiran for inadequately controlled hypertension: KARDIA-2 RCT
thumbnail
Congress Presentation
When to start drug treatment and new blood pressure treatment targets

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources